Unchanged rat brain amyloid precursor protein levels after exposure to benzodiazepines in vivo

European Journal of Anaesthesiology

Volumn 23, Issue 9, 2006, Pages 772-775

  Kalman J ^a   Palotas M ^a   Pakaski M ^a   Hugyecz, M ^a   Janka, Z ^a   Palotas A ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer disease; Amyloid beta protein precursor; Anaesthesia general; Benzodiazepines, diazepam, midazolam; Postoperative period, cognitive dysfunction

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MIDAZOLAM; MIDAZOLAM MALEATE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; GENERAL ANESTHESIA; MALE; NEUROTOXICITY; NONHUMAN; POSTOPERATIVE PERIOD; PROTEIN DETERMINATION; PROTEIN METABOLISM; RAT; RISK ASSESSMENT; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; ANESTHESIA, GENERAL; ANIMALS; ANTIBODIES, MONOCLONAL; BENZODIAZEPINES; BRAIN; DIAZEPAM; MALE; MIDAZOLAM; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY; RISK;

EID: 33746921615     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000494     Document Type: Article

References (20)

1. Roach GW, Kanchuger M, Mangano CM et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators. New Engl J Med 1996; 335: 1857-1863.
2. Mullges W, Berg D, Schmidtke A, Weinacker B, Toyka KV. Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med 2000; 28: 1808-1811.
3. Bohnen NI, Warner MA, Kokmen E, Beard CM, Kurland LT. Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc 1994; 42: 198-201.
4. Breteler MM, van Duijn CM, Chandra V et al. Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM risk factors research group. Int J Epidemiol 1991; 20: S36-S42.
5. Gasparini M, Vanacore N, Schiaffini C et al. A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci 2002; 23: 11-14.
6. Brown WR, Moody DM, Tytell M, Ghazi-Birry HS, Challa VR. Microembolic brain injuries from cardiac surgery: are they seeds of future Alzheimer's disease? Ann N Y Acad Sci 1997; 826: 386-389.
7. Newman MF, Kirchner JL, Phillips-Bute B et al. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med 2001; 344: 395-402.
8. Selnes OA, Royall RM, Grega MA, Borowicz Jr LM, Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting is there evidence of late decline? Arch Neurol 2001; 58: 598-604.
9. Selkoe DJ, Abraham CR, Podlisny MB, Duffy LK. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem 1986; 46: 1820-1834.
10. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 1992; 593: 128-135.
11. Hess HH, Lees MB, Derr JE. A linear Lowry-Folin assay for both water-soluble and sodium dodecyl sulfate-solubilized proteins. Ann Biochem 1978; 85: 295-300.
12. Farr SA, Uezu K, Flood JF, Morley JE. Septohippocampal drug interactions in post-trial memory processing. Brain Res 1999; 847: 221-230.
13. Fastbom J, Forsell Y, Winblad B. Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12: 14-17.
14. Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 1988; 111: 785-799.
15. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 1982; 105: 313-330.
16. Churcher I, Ashton K, Butcher JW et al. A new series of potent benzodiazepine γ-secretase inhibitors. Bioorg Med Chem Lett 2003; 13: 179-183.
17. Lund C, Hol PK, Lundblad R et al. Comparison of cerebral embolization during off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg 2003; 76: 765-770.
18. Russell D. Cerebral microemboli and cognitive impairment. J. Neurol Sci 2002; 203-204, 211-214.
19. Palotás A, Bogáts G, Babik B et al. Coronary artery bypass surgery provokes Alzheimer's disease-like changes in the cerebrospinal fluid. 2006 (submitted).
20. Kálmán J, Juhász A, Bogáts G, Babik B. Ramanóczy Á, Janka Z, Penke B, Palotás A. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int 2006; 48(3): 177-180.